MatriDerm

A hybrid mesh medical device combining collagen sheet and polycaprolactone (PCL) mesh manufactured using 3D printing technology. It is used for reinforcement and reconstruction of damaged soft tissues such as muscle and abdominal wall. The device is biodegradable, naturally dissolves in the body over approximately 6 months, and regenerates as tissue while reducing adhesion problems. It addresses issues associated with cadaver-derived dermal grafts including high cost, inflammatory response, and supply imbalance.

A medical device product from PLCOSKIN's product portfolio designed for tissue regeneration and soft tissue reconstruction.

Medical devices incorporating collagen technology for therapeutic applications. Designed to meet clinical requirements across multiple medical specialty areas.

Biocompatible collagen stimulator based on biodegradable polymer technology for soft tissue augmentation and regenerative applications. Promotes natural collagen production for tissue reconstruction.

A graft version of the TissueDerm hybrid mesh technology for soft tissue reconstruction and tissue regeneration applications.

Engineered extracellular matrix-based product for tissue regeneration and wound healing. Promotes cellular growth, differentiation, and tissue remodeling through biomaterial scaffolding. Indicated for traumatic injuries and chronic wound management.

Acellular Dermal Matrix

Medical devices formulated for dermatological and skin care applications. These products are designed to support treatment of various skin conditions and dermatological procedures.

Matrixflex™ is a regenerative biomaterial scaffold designed for tissue repair and regeneration across orthopedic, dental, and surgical applications. The product leverages advanced biomaterial science to support cellular integration and tissue restoration, with FDA registration and 170+ global regulatory approvals. Matrixflex™ is manufactured under ISO 13485 and MDSAP-certified processes, supporting clinical outcomes in regenerative medicine.

A regenerative medicine material produced through proprietary decellularization technology applied to porcine omentum-derived extracellular matrix. The product is indicated for wound care and tissue reconstruction in clinical applications.

Medical device designed to physically lift or secure skin tissue, improving the appearance of sagging skin. Provides mechanical support for skin rejuvenation procedures.

A dressing product with recombinant type III humanized collagen protein as the main component, prepared using freeze-drying technology and provided in a fixed-liquid separation package for immediate use. It rapidly replenishes extracellular matrix components and stimulates fibroblast metabolism and proliferation to promote endogenous collagen synthesis and regeneration. The product is indicated for non-chronic wounds including shallow surface wounds, post-surgical sutured wounds, mechanical trauma, minor cuts, abrasions, laser/photon/chemical peel wounds, and minor thermal burns, providing microenvironment support for wound healing.